Exacerbating Guillain–Barré Syndrome Eight Days after Vector-Based COVID-19 Vaccination
Since the introduction of mRNA technology-based and vector-based COVID-19 vaccines, adverse reactions to these agents have been occasionally reported. Exacerbation of Guillain–Barré syndrome (GBS) shortly after COVID-19 vaccination has not been communicated. The patient is a 32-year-old male who dev...
Saved in:
Main Author: | Josef Finsterer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2021/3619131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Guillain-Barré Syndrome due to CMV Reactivation after Cardiac Transplantation
by: Christina Maria Steger, et al.
Published: (2012-01-01) -
Cardiogenic Shock and Guillain–Barré Syndrome as the First Manifestations of Pheochromocytoma
by: Maryam Heidarpour, et al.
Published: (2021-01-01) -
Isolated Bilateral Ptosis as an Early Sign of Guillain-Barré Syndrome
by: Yahia Z. Imam, et al.
Published: (2013-01-01) -
Successful treatment of anorexia nervosa and alleviation of chronic Guillain Barré syndrome
by: Andreas Richterich, et al.
Published: (2011-02-01) -
A Case of Systemic Lupus Erythematosus Presenting as Guillain-Barré Syndrome
by: Helen Chioma Okoh, et al.
Published: (2015-01-01)